Bemfivastatin (hemicalcium) - HY-106281A
Nur noch %1 verfügbar
Catalog #
HY-106281A
Ab
155,00 €
Bemfivastatin (PPD 10558) hemicalcium is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin hemicalcium enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin hemicalcium can be used for research of metabolic disease, such as hypercholesterolemia[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-106281A/Bemfivastatin-hemicalcium-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Metabolism-sugar/lipid metabolism |
| Alternative Names | PPD 10558 (hemicalcium) |
| CAS | 805241-64-9 |
| Storage | 4°C (Powder, sealed storage, away from moisture and light) |
| MWT | 607.74 |
| Solubility | DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | HMG-CoA Reductase (HMGCR) |
| Application: | Metabolism-sugar/lipid metabolism |
|---|